Kanawha Capital Management LLC Sells 125 Shares of Colgate-Palmolive (NYSE:CL)

Kanawha Capital Management LLC reduced its stake in Colgate-Palmolive (NYSE:CL) by 0.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 74,697 shares of the company’s stock after selling 125 shares during the period. Kanawha Capital Management LLC’s holdings in Colgate-Palmolive were worth $6,791,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in CL. Creative Planning increased its holdings in shares of Colgate-Palmolive by 2.0% in the 3rd quarter. Creative Planning now owns 218,018 shares of the company’s stock worth $22,632,000 after buying an additional 4,372 shares during the last quarter. NBC Securities Inc. increased its holdings in shares of Colgate-Palmolive by 49.3% in the 3rd quarter. NBC Securities Inc. now owns 5,463 shares of the company’s stock worth $567,000 after buying an additional 1,804 shares during the last quarter. Swedbank AB increased its holdings in shares of Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after buying an additional 40,324 shares during the last quarter. SeaCrest Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 7.4% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 7,261 shares of the company’s stock worth $754,000 after buying an additional 502 shares during the last quarter. Finally, Sumitomo Life Insurance Co. increased its holdings in shares of Colgate-Palmolive by 3.0% in the 3rd quarter. Sumitomo Life Insurance Co. now owns 10,283 shares of the company’s stock worth $1,067,000 after buying an additional 298 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Price Performance

NYSE:CL opened at $87.87 on Friday. The company has a 50 day moving average price of $89.83 and a 200-day moving average price of $96.54. Colgate-Palmolive has a 1-year low of $82.83 and a 1-year high of $109.30. The firm has a market cap of $71.79 billion, a price-to-earnings ratio of 24.96, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company posted $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Analyst Ratings Changes

A number of research firms have recently weighed in on CL. Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. UBS Group dropped their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.